Familial Alzheimer’s Disease and Recessive Modifiers
Open Access
- 29 October 2019
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 57 (2) , 1035-1043
Abstract
Alzheimer’s disease (AD) is progressive brain disorder that affects ~ 50 million people worldwide and has no current effective treatment. AD age of onset (ADAOO) has shown to be critical for the identification of genes that modify the appearance of AD signs and symptoms in a specific population. We clinically characterized and whole-exome genotyped 71 individuals with AD from thePaisagenetic isolate, segregating the (PSEN1) E280A dominant fully penetrant mutation, and analyzed the potential recessive effects of ~ 50,000 common functional genomic variants to the ADAOO. Standard quality control and filtering procedures were applied, and recessive single- and multi-locus linear mixed-effects models were used. We identified genetic variants in theSLC9C1,CSN1S1, andLOXL4acting recessively to delay ADAOO up to ~ 11, ~ 6, and ~ 9 years on average, respectively. In contrast, the CC recessive genotype in markerDHRS4L2-rs2273946 accelerates ADAOO by ~ 8 years. This study, reports new recessive variants modifying ADAOO inPSEN1E280A mutation carriers. This set of genes are implicated in important biological processes and molecular functions commonly affected by genes associated with the etiology of AD such asAPP,APOE, andCLU. Future functional studies using modern techniques such as induced pluripotent stem cells will allow a better understanding of the over expression and down regulation of these recessive modifier variants and hence the pathogenesis of AD. These results are important for prediction of AD and ultimately, substantial to develop new therapeutic strategies for individuals at risk or affected by AD.Keywords
This publication has 61 references indexed in Scilit:
- The human gene connectome as a map of short cuts for morbid allele discoveryProceedings of the National Academy of Sciences, 2013
- Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs – an integral molecular/biochemical/metabolic/clinical approach after one hundred years of cancer researchJournal of Translational Medicine, 2013
- Detecting Rare Variant Effects Using Extreme Phenotype Sampling in Sequencing Association StudiesGenetic Epidemiology, 2012
- AS1DHRS4, a head-to-head natural antisense transcript, silences the DHRS4 gene cluster in cis and transProceedings of the National Academy of Sciences, 2012
- Pooling/bootstrap-based GWAS (pbGWAS) identifies new loci modifying the age of onset in PSEN1 p.Glu280Ala Alzheimer's diseaseMolecular Psychiatry, 2012
- An efficient multi-locus mixed-model approach for genome-wide association studies in structured populationsNature Genetics, 2012
- Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++PLOS Computational Biology, 2010
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- A Recessive Mutation in the APP Gene with Dominant-Negative Effect on AmyloidogenesisScience, 2009
- Modulation by age and gender of risk for Alzheimer's disease and vascular dementia associated with the apolipoprotein E-ε4 allele in Latin Americans: findings from the Maracaibo Aging StudyNeuroscience Letters, 2001